Finzati - Logo
ERNA logo

Ernexa Therapeutics Inc.

ERNABiotechnology
$4.31
-0.22 (-4.86%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.35M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 60.2%Manageable debt level · 0.2Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 1:14 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$4.31
Change-4.86%
Market Cap$1.35M
52W Range3.18 - 71.50
Beta2.56
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.20
Current Ratio1.01
Quick Ratio1.01
Revenue 5Y-100.00%

Investment DNA

How strong this company looks for long-term investors

50
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
56/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
77/100
Why this score
Positive revenue growth · 60.2%Manageable debt level · 0.2Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 8/29/1991
Industry: Biotechnology
P/B i: 3.15
Debt / Equity i: 0.20
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score11 / 20
Debt / Equity: 0.20
Current Ratio: 1.01
Quick Ratio: 1.01
Status: Moderate

Insider Transactions

Recent executive and insider activity

1 high-volume insider sell detected
Cherington Charles
Transaction: 02/10/2026
BUY
Change
+4,000,000
Price
$0.68
Filing
02/17/2026
Type
BUY
Cherington Charles
Transaction: 02/10/2026
BUY
Change
+4,000,000
Price
$0.50
Filing
02/17/2026
Type
BUY
Gurrola Sandra M
Transaction: 06/21/2025
BUY
Change
+30
Price
Not reported
Filing
07/07/2025
Type
BUY